Annotation Detail for RARA
Basic Information Top
Gene Symbol: | RARA ( NR1B1,RAR ) |
---|---|
Gene Full Name: | retinoic acid receptor, alpha |
Band: | 17q21.2 |
Quick Links | Entrez ID:5914; OMIM: 180240; Uniprot ID:RARA_HUMAN; ENSEMBL ID: ENSG00000131759; HGNC ID: 9864 |
Relate to Another Database: | SFARIGene; denovo-db |
No data |
Pathway ID | Pathway Name |
---|---|
hsa05221 | Acute myeloid leukemia |
hsa05200 | Pathways in cancer |
Pathway ID | Pathway Name |
---|---|
Gene Expression |
Pathway ID | Pathway Name |
---|---|
200142 | Retinoic acid receptors-mediated signaling |
200112 | RXR and RAR heterodimerization with other nuclear receptor |
Pathway ID | Pathway Name |
---|---|
P04396 | Vitamin D metabolism and pathway |
No data |
Desease ID | Desease Name |
---|---|
Cancers of haematopoietic and lymphoid tissues | |
Cancers | |
H00003 | Acute myeloid leukemia (AML) |
Desease ID | Desease Name |
---|---|
1781 | Rheumatoid arthritis |
1831 | Prostate cancer |
1856 | Obesity |
1944 | Breast cancer |
1993 | Esophagus cancer |
2011 | Leukoencephalopathy |
2051 | Leukemia |
Desease Name |
---|
DEVELOPMENTAL |
cleft lip with cleft palate cleft lip without cleft palate |
No data |
Desease Name |
---|
Leukemia, acute promyelocytic |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C496751 | 4-(1H-imidazol-1-yl)retinoic acid | 4-(1H-imidazol-1-yl)retinoic acid binds to RARA protein | affects binding | 17387344 |
C038864 | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid binds to and results in increased activity of RARA protein | affects binding|increases activity | 15589975 16178010 |
C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in decreased expression of RARA mRNA | decreases expression | 18648102 |
C064545 | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid binds to RARA protein | affects binding | 15589975 |
C002202 | 4-oxoretinoic acid | 4-oxoretinoic acid results in increased expression of RARA mRNA | increases expression | 17034753 |
C041819 | 4-oxoretinol | 4-oxoretinol results in increased expression of RARA mRNA | increases expression | 17034753 |
C096920 | AGN 193109 | AGN 193109 binds to and results in decreased activity of RARA protein | affects binding|decreases activity | 15589975 |
C096920 | AGN 193109 | AGN 193109 binds to and results in decreased activity of RARA protein | affects binding|decreases activity | 16982809 |
C121616 | AGN 194310 | AGN 194310 binds to and results in decreased activity of RARA protein | affects binding|decreases activity | 16178010 |
C492393 | AGN 195183 | AGN 195183 binds to and results in increased activity of RARA protein | affects binding|increases activity | 16178010 |
C492393 | AGN 195183 | AGN 195183 binds to and results in increased activity of RARA protein | affects binding|increases activity | 17318068 |
D019386 | Alendronate | Alendronate affects the expression of RARA mRNA | affects expression | 16079270 |
C103303 | alitretinoin | alitretinoin promotes the reaction [RARA protein binds to PRAME protein] | affects binding|increases reaction | 16179254 |
C103303 | alitretinoin | alitretinoin results in decreased expression of RARA protein | decreases expression | 15375546 |
C103303 | alitretinoin | alitretinoin results in increased expression of RARA mRNA | increases expression | 11139446 17034753 |
C103303 | alitretinoin | RARA protein promotes the reaction [alitretinoin results in increased expression of ABCC6 mRNA] | increases expression|increases reaction | 17045963 |
C103303 | alitretinoin | alitretinoin results in increased expression of RARA mRNA | increases expression | 8892963 |
C103303 | alitretinoin | alitretinoin results in increased expression of RARA protein | increases expression | 16043492 |
C103303 | alitretinoin | [Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein] | affects cotreatment|increases activity|increases reaction | 15773917 |
C103303 | alitretinoin | CAMK4 protein promotes the reaction [alitretinoin results in increased activity of RARA protein] | increases activity|increases reaction | 15773917 |
C103303 | alitretinoin | Dizocilpine Maleate inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
C103303 | alitretinoin | KN 62 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
C103303 | alitretinoin | Okadaic Acid promotes the reaction [alitretinoin results in increased activity of RARA protein] | increases activity|increases reaction | 15773917 |
C103303 | alitretinoin | STO 609 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
C103303 | alitretinoin | trichostatin A promotes the reaction [alitretinoin results in increased activity of RARA protein] | increases activity|increases reaction | 15773917 |
C068073 | Am 580 | Am 580 binds to and results in increased activity of RARA protein | affects binding|increases activity | 10779427 16178010 |
C068073 | Am 580 | Am 580 results in increased expression of RARA protein | increases expression | 16636311 |
C068073 | Am 580 | Am 580 binds to and affects the activity of RARA protein | affects activity|affects binding | 16982809 |
C068073 | Am 580 | Am 580 binds to and results in increased activity of RARA protein | affects binding|increases activity | 15855632 17392484 |
C068073 | Am 580 | Am 580 results in increased activity of RARA protein | increases activity | 17460283 |
C061133 | Am 80 | Am 80 binds to and affects the activity of RARA protein | affects activity|affects binding | 16982755 |
C061133 | Am 80 | Am 80 binds to and results in increased activity of RARA protein | affects binding|increases activity | 16819260 |
D015761 | 4-Aminopyridine | [Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein] | affects cotreatment|increases activity|increases reaction | 15773917 |
D015761 | 4-Aminopyridine | Dizocilpine Maleate inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
D015761 | 4-Aminopyridine | KN 62 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
D015761 | 4-Aminopyridine | STO 609 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of RARA mRNA | affects expression | 16483693 |
D000966 | Antimony Potassium Tartrate | Antimony Potassium Tartrate results in increased degradation of RARA protein mutant form | increases degradation | 9834237 |
C037554 | antimony trioxide | antimony trioxide results in increased degradation of RARA protein mutant form | increases degradation | 9834237 |
C004984 | apocarotenal | apocarotenal results in decreased expression of RARA mRNA | decreases expression | 17034753 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [puerarin results in decreased expression of RARA mRNA alternative form] | decreases expression|increases reaction | 20416161 |
C006632 | arsenic trioxide | arsenic trioxide results in increased degradation of RARA protein mutant form | increases degradation | 16891316 15748426 9834237 |
C006632 | arsenic trioxide | cobaltous chloride promotes the reaction [arsenic trioxide results in increased degradation of RARA protein mutant form] | increases degradation|increases reaction | 16330433 |
C006632 | arsenic trioxide | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of RARA mRNA alternative form | affects cotreatment|decreases expression | 19225113 |
C006632 | arsenic trioxide | arsenic trioxide results in increased degradation of and results in decreased expression of RARA protein | decreases expression|increases degradation | 15688020 |
C045816 | arsenic trisulfide | arsenic trisulfide results in increased degradation of and results in decreased expression of RARA protein | decreases expression|increases degradation | 12513809 |
C045816 | arsenic trisulfide | arsenic trisulfide results in increased degradation of and results in decreased expression of RARA protein mutant form | decreases expression|increases degradation | 12513809 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene affects the activity of RARA protein | affects activity | 20624995 |
D019207 | beta Carotene | beta Carotene results in decreased expression of RARA mRNA | decreases expression | 17034753 |
D001640 | Bicuculline | [Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein] | affects cotreatment|increases activity|increases reaction | 15773917 |
D001640 | Bicuculline | Dizocilpine Maleate inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
D001640 | Bicuculline | KN 62 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
D001640 | Bicuculline | STO 609 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
C006780 | bisphenol A | bisphenol A results in decreased expression of RARA mRNA | decreases expression | 14967906 |
C006780 | bisphenol A | bisphenol A results in increased expression of RARA mRNA | increases expression | 15738621 14967906 |
D002087 | Butyrates | [Tretinoin co-treated with Butyrates] results in increased cleavage of RARA protein mutant form | affects cotreatment|increases cleavage | 12130515 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester promotes the reaction [Tretinoin results in increased activity of RARA protein] | increases activity|increases reaction | 16766008 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in increased activity of RARA protein | increases activity | 16766008 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in increased expression of RARA mRNA | increases expression | 16766008 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in increased expression of RARA protein | increases expression | 16766008 |
C055494 | caffeic acid phenethyl ester | [Tretinoin co-treated with caffeic acid phenethyl ester] results in increased expression of RARA mRNA | affects cotreatment|increases expression | 16766008 |
C055494 | caffeic acid phenethyl ester | [Tretinoin co-treated with caffeic acid phenethyl ester] results in increased expression of RARA protein | affects cotreatment|increases expression | 16766008 |
D002746 | Chlorpromazine | Chlorpromazine results in decreased expression of RARA mRNA | decreases expression | 18246545 |
C018021 | cobaltous chloride | cobaltous chloride promotes the reaction [arsenic trioxide results in increased degradation of RARA protein mutant form] | increases degradation|increases reaction | 16330433 |
D003474 | Curcumin | Curcumin inhibits the reaction [TGFB1 protein results in increased expression of RARA mRNA] | decreases reaction|increases expression | 8940178 |
C014347 | decitabine | [decitabine co-treated with Tretinoin] results in increased expression of RARA mRNA | affects cotreatment|increases expression | 19524134 |
C014347 | decitabine | decitabine promotes the reaction [vorinostat results in increased expression of RARA mRNA] | increases expression|increases reaction | 17417771 |
D003840 | Deoxycholic Acid | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of RARA mRNA | affects cotreatment|increases expression | 16556975 |
D003907 | Dexamethasone | Dexamethasone results in increased expression of RARA mRNA | increases expression | 19022236 |
D002945 | Cisplatin | Cisplatin results in increased expression of RARA mRNA | increases expression | 18172885 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA | affects cotreatment|decreases expression | 18544905 |
D004052 | Diethylnitrosamine | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA | affects cotreatment|decreases expression | 18253720 |
D016291 | Dizocilpine Maleate | Dizocilpine Maleate inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased expression of RARA mRNA | increases expression | 12628509 |
D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of RARA mRNA | affects cotreatment|decreases expression | 19619570 |
D004958 | Estradiol | Estradiol results in decreased expression of RARA mRNA | decreases expression | 19619570 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of RARA mRNA | affects expression | 17555576 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of RARA mRNA | increases expression | 17942748 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RARA mRNA | affects cotreatment|increases expression | 17942748 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of RARA mRNA | affects expression | 16079270 |
D011345 | Fenofibrate | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA | affects cotreatment|decreases expression | 18253720 |
D005839 | Gentamicins | Gentamicins results in increased expression of RARA mRNA | increases expression | 18172885 |
C030691 | gluconic acid | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of RARA mRNA | affects cotreatment|increases expression | 16556975 |
D006118 | Griseofulvin | Griseofulvin results in increased expression of RARA mRNA | increases expression | 9548566 |
D019307 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [TGFB1 protein results in increased expression of RARA mRNA] | decreases reaction|increases expression | 8940178 |
C014026 | hexamethylene bisacetamide | [Tretinoin co-treated with hexamethylene bisacetamide] results in increased cleavage of RARA protein mutant form | affects cotreatment|increases cleavage | 12130515 |
D017313 | Fenretinide | Fenretinide results in decreased expression of RARA protein | decreases expression | 15375546 |
D017313 | Fenretinide | Fenretinide results in increased expression of RARA mRNA | increases expression | 15735044 |
D006918 | Hydroxyurea | Hydroxyurea results in increased mutagenesis of RARA gene | increases mutagenesis | 16868089 |
C063302 | KN 62 | KN 62 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA | affects cotreatment|decreases expression | 18544905 |
C008281 | limonene | limonene results in decreased expression of RARA mRNA | decreases expression | 12815608 |
D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [Tretinoin results in increased expression of RARA mRNA] | increases expression|increases reaction | 17216566 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of RARA protein | decreases expression | 16002565 |
D008550 | Melatonin | Melatonin promotes the reaction [Tretinoin results in increased activity of RARA protein] | increases activity|increases reaction | 15813899 |
D008770 | Methylnitrosourea | Methylnitrosourea results in increased mutagenesis of RARA gene | increases mutagenesis | 16868089 |
C007350 | nitrofen | nitrofen results in increased expression of RARA mRNA | increases expression | 17270546 |
C508934 | N-retinoylglucosamine | N-retinoylglucosamine results in increased expression of RARA mRNA | increases expression | 16280019 |
D019319 | Okadaic Acid | Okadaic Acid promotes the reaction [alitretinoin results in increased activity of RARA protein] | increases activity|increases reaction | 15773917 |
D010672 | Phenytoin | Phenytoin results in decreased expression of RARA mRNA | decreases expression | 9118846 |
D010672 | Phenytoin | Phenytoin results in increased expression of RARA mRNA | increases expression | 9988880 |
D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls results in increased expression of RARA protein | increases expression | 17287035 |
C033607 | puerarin | arsenic trioxide promotes the reaction [puerarin results in decreased expression of RARA mRNA alternative form] | decreases expression|increases reaction | 20416161 |
C033607 | puerarin | puerarin results in decreased expression of RARA mRNA alternative form | decreases expression | 20416161 |
D020849 | Raloxifene | Raloxifene affects the expression of RARA mRNA | affects expression | 16079270 |
D015474 | Isotretinoin | Isotretinoin results in increased expression of RARA mRNA | increases expression | 9262057 |
D012176 | Retinoids | RARA protein promotes the reaction [Retinoids results in increased expression of FOXK2 mRNA] | increases expression|increases reaction | 12075115 |
D012176 | Retinoids | RARA protein promotes the reaction [Retinoids results in increased expression of TGM2 mRNA] | increases expression|increases reaction | 12075115 |
D012176 | Retinoids | Retinoids binds to and results in increased activity of RARA protein | affects binding|increases activity | 12075115 |
C014794 | retinol palmitate | retinol palmitate promotes the reaction [RARA protein binds to MMP9 protein] | affects binding|increases reaction | 17164434 |
C084904 | Ro 41-5253 | Ro 41-5253 binds to and results in decreased activity of RARA protein | affects binding|decreases activity | 7556191 10779427 |
C084904 | Ro 41-5253 | Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of RARA mRNA] | decreases reaction|increases expression | 17216566 |
C084904 | Ro 41-5253 | Ro 41-5253 binds to and results in decreased activity of RARA protein | affects binding|decreases activity | 8838863 |
C084904 | Ro 41-5253 | Ro 41-5253 binds to and results in decreased activity of RARA protein | affects binding|decreases activity | 16085646 16872382 |
D012967 | Sodium Dodecyl Sulfate | Sodium Dodecyl Sulfate results in decreased expression of RARA mRNA | decreases expression | 12815608 |
C458525 | STO 609 | STO 609 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15773917 |
D014284 | Triiodothyronine | Triiodothyronine results in increased expression of RARA mRNA | increases expression | 17403546 |
D013629 | Tamoxifen | Tamoxifen affects the expression of RARA mRNA | affects expression | 17555576 |
D013739 | Testosterone | Testosterone results in decreased expression of RARA mRNA | decreases expression | 16432891 |
D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of RARA mRNA | affects cotreatment|decreases expression | 19619570 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of RARA mRNA | decreases expression | 19619570 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RARA mRNA | affects cotreatment|increases expression | 17942748 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of RARA mRNA | increases expression | 15667827 |
D013876 | Thiophenes | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of RARA mRNA alternative form] | increases expression|increases reaction | 16140955 |
D014212 | Tretinoin | Tretinoin results in increased expression of RARA mRNA | increases expression | 12921748 |
D014212 | Tretinoin | caffeic acid phenethyl ester promotes the reaction [Tretinoin results in increased activity of RARA protein] | increases activity|increases reaction | 16766008 |
D014212 | Tretinoin | [decitabine co-treated with Tretinoin] results in increased expression of RARA mRNA | affects cotreatment|increases expression | 19524134 |
D014212 | Tretinoin | IFNG protein promotes the reaction [Tretinoin results in increased expression of RARA mRNA] | increases expression|increases reaction | 16007204 |
D014212 | Tretinoin | Lipopolysaccharides promotes the reaction [Tretinoin results in increased expression of RARA mRNA] | increases expression|increases reaction | 17216566 |
D014212 | Tretinoin | Melatonin promotes the reaction [Tretinoin results in increased activity of RARA protein] | increases activity|increases reaction | 15813899 |
D014212 | Tretinoin | [PCNA protein binds to RARA protein] which affects the susceptibility to Tretinoin | affects binding|affects response to substance | 16055921 |
D014212 | Tretinoin | RARA protein affects the reaction [Tretinoin results in decreased secretion of IFNG protein] | affects reaction|decreases secretion | 16872382 |
D014212 | Tretinoin | RARA protein affects the reaction [Tretinoin results in decreased secretion of [IL12A protein binds to IL12B protein]] | affects binding|affects reaction|decreases secretion | 16872382 |
D014212 | Tretinoin | RARA protein affects the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] | affects reaction|increases expression | 16194896 |
D014212 | Tretinoin | RARA protein affects the reaction [Tretinoin results in increased secretion of IL10 protein] | affects reaction|increases secretion | 16872382 |
D014212 | Tretinoin | RARA protein affects the reaction [Tretinoin results in increased secretion of IL4 protein] | affects reaction|increases secretion | 16872382 |
D014212 | Tretinoin | [RARA protein binds to RXRA protein] promotes the reaction [Tretinoin results in increased degradation of NCOA3 protein] | affects binding|increases degradation|increases reaction | 16456540 |
D014212 | Tretinoin | RARA protein promotes the reaction [Tretinoin results in increased activity of STS protein] | increases activity|increases reaction | 16178010 |
D014212 | Tretinoin | RARA protein promotes the reaction [Tretinoin results in increased expression of VEGFA mRNA] | increases expression|increases reaction | 17170094 |
D014212 | Tretinoin | RARA protein results in increased susceptibility to Tretinoin | increases response to substance | 16287870 |
D014212 | Tretinoin | Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of RARA mRNA] | decreases reaction|increases expression | 17216566 |
D014212 | Tretinoin | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of RARA mRNA alternative form] | increases expression|increases reaction | 16140955 |
D014212 | Tretinoin | Tretinoin affects the localization of RARA protein | affects localization | 16636311 |
D014212 | Tretinoin | [Tretinoin binds to and affects the activity of RARA protein] which results in increased activity of CDKN1A protein | affects activity|affects binding|increases activity | 16765349 |
D014212 | Tretinoin | Tretinoin binds to [RXRA protein binds to RARA protein] | affects binding | 16757381 |
D014212 | Tretinoin | [Tretinoin binds to [RXRA protein binds to RARA protein]] which binds to PDK4 promoter | affects binding | 16757381 |
D014212 | Tretinoin | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of RARA mRNA alternative form | affects cotreatment|decreases expression | 19225113 |
D014212 | Tretinoin | [Tretinoin co-treated with Butyrates] results in increased cleavage of RARA protein mutant form | affects cotreatment|increases cleavage | 12130515 |
D014212 | Tretinoin | [Tretinoin co-treated with caffeic acid phenethyl ester] results in increased expression of RARA mRNA | affects cotreatment|increases expression | 16766008 |
D014212 | Tretinoin | [Tretinoin co-treated with caffeic acid phenethyl ester] results in increased expression of RARA protein | affects cotreatment|increases expression | 16766008 |
D014212 | Tretinoin | [Tretinoin co-treated with hexamethylene bisacetamide] results in increased cleavage of RARA protein mutant form | affects cotreatment|increases cleavage | 12130515 |
D014212 | Tretinoin | [Tretinoin co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA | affects cotreatment|increases expression | 17244623 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [BTG2 protein binds to RARA protein] | affects binding|decreases reaction | 16782888 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [CCNH protein binds to and results in increased phosphorylation of RARA protein mutant form] | affects binding|decreases reaction|increases phosphorylation | 16935935 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [PRMT1 protein binds to RARA protein] | affects binding|decreases reaction | 16782888 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [RARA protein mutant form results in decreased expression of SPI1 mRNA] | decreases expression|decreases reaction | 16352814 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [RARA protein mutant form results in decreased expression of SPI1 protein] | decreases expression|decreases reaction | 16352814 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [SIN3A protein binds to RARA protein] | affects binding|decreases reaction | 16782888 |
D014212 | Tretinoin | Tretinoin promotes the reaction [CREBBP protein binds to RARA protein] | affects binding|increases reaction | 16417649 |
D014212 | Tretinoin | Tretinoin promotes the reaction [NCOA3 protein binds to RARA protein] | affects binding|increases reaction | 16456540 |
D014212 | Tretinoin | Tretinoin promotes the reaction [PCNA protein binds to RARA protein] | affects binding|increases reaction | 16055921 |
D014212 | Tretinoin | Tretinoin promotes the reaction [RARA protein binds to CD1D promoter] | affects binding|increases reaction | 17392484 |
D014212 | Tretinoin | Tretinoin promotes the reaction [RARA protein binds to FOLR2 promoter] | affects binding|increases reaction | 16740727 |
D014212 | Tretinoin | Tretinoin promotes the reaction [RARA protein binds to PRAME protein] | affects binding|increases reaction | 16179254 |
D014212 | Tretinoin | Tretinoin promotes the reaction [[RARA protein binds to RXRA protein] which binds to NOS2A promoter] | affects binding|increases reaction | 17306764 |
D014212 | Tretinoin | Tretinoin results in decreased expression of RARA protein | decreases expression | 15194426 15375546 16740359 |
D014212 | Tretinoin | Tretinoin results in increased activity of RARA protein | increases activity | 16766008 |
D014212 | Tretinoin | Tretinoin results in increased activity of [RARA protein binds to RXRA protein] | affects binding|increases activity | 20008677 |
D014212 | Tretinoin | Tretinoin results in increased cleavage of RARA protein mutant form | increases cleavage | 12130515 |
D014212 | Tretinoin | Tretinoin results in increased degradation of RARA protein | increases degradation | 16456540 |
D014212 | Tretinoin | Tretinoin results in increased degradation of RARA protein mutant form | increases degradation | 9834237 15748426 19029980 16352814 |
D014212 | Tretinoin | Tretinoin results in increased expression of and results in increased activity of RARA protein | increases activity|increases expression | 16158052 |
D014212 | Tretinoin | Tretinoin results in increased expression of RARA mRNA | increases expression | 16007204 17138961 17216566 17034753 16766008 |
D014212 | Tretinoin | Tretinoin results in increased expression of RARA mRNA alternative form | increases expression | 16140955 |
D014212 | Tretinoin | Tretinoin results in increased expression of RARA protein | increases expression | 16636311 16766008 |
D014212 | Tretinoin | Tretinoin results in increased phosphorylation of RARA protein mutant form | increases phosphorylation | 19029980 |
D014212 | Tretinoin | ZNF366 protein promotes the reaction [Tretinoin results in increased activity of [RARA protein binds to RXRA protein]] | affects binding|increases activity|increases reaction | 20008677 |
D014212 | Tretinoin | RARA protein affects the reaction [Tretinoin affects the expression of CYP26A1 mRNA] | affects expression|affects reaction | 16261163 |
D014212 | Tretinoin | RARA protein affects the reaction [Tretinoin affects the expression of RARB mRNA] | affects expression|affects reaction | 16261163 |
D014212 | Tretinoin | RARA protein inhibits the reaction [Tretinoin results in increased activity of [CLOCK protein binds to ARNTL protein]] | affects binding|decreases reaction|increases activity | 17069763 |
D014212 | Tretinoin | Tretinoin binds to and results in increased activity of RARA protein | affects binding|increases activity | 16839186 12504905 |
D014212 | Tretinoin | [Tretinoin binds to RARA protein] which binds to NRL promoter | affects binding | 16854989 |
D014212 | Tretinoin | Tretinoin results in decreased expression of RARA protein | decreases expression | 15646024 |
D014212 | Tretinoin | Tretinoin results in increased expression of RARA mRNA | increases expression | 8892963 |
D014212 | Tretinoin | IL1B protein promotes the reaction [Tretinoin affects the localization of RARA protein] | affects localization|increases reaction | 17078027 |
D014212 | Tretinoin | Tretinoin affects the localization of RARA protein | affects localization | 17078027 |
D014212 | Tretinoin | Tretinoin results in increased expression of RARA protein | increases expression | 16043492 |
D014212 | Tretinoin | Tretinoin binds to and results in increased activity of RARA protein | affects binding|increases activity | 16839186 |
D014212 | Tretinoin | Tretinoin binds to and results in increased activity of RARA protein | affects binding|increases activity | 16819260 |
D014212 | Tretinoin | Tretinoin binds to RARA protein | affects binding | 17387344 |
C012589 | trichostatin A | trichostatin A promotes the reaction [alitretinoin results in increased activity of RARA protein] | increases activity|increases reaction | 15773917 |
C034028 | vanadyl sulfate | vanadyl sulfate results in decreased expression of RARA mRNA | decreases expression | 16330358 |
D014801 | Vitamin A | Vitamin A results in increased expression of RARA mRNA | increases expression | 12921748 |
D014801 | Vitamin A | [Vitamin A co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA | affects cotreatment|increases expression | 17244623 |
D014801 | Vitamin A | Vitamin A results in increased expression of RARA mRNA | increases expression | 17225872 17034753 |
D014801 | Vitamin A | [RARA gene mutant form co-treated with Vitamin A] results in decreased expression of COL2A1 mRNA | affects cotreatment|decreases expression | 16397886 |
D014801 | Vitamin A | [RARA gene mutant form co-treated with Vitamin A] results in decreased expression of SOX9 mRNA | affects cotreatment|decreases expression | 16397886 |
D014801 | Vitamin A | [RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS1 mRNA | affects cotreatment|increases expression | 16397886 |
D014801 | Vitamin A | [RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA | affects cotreatment|increases expression | 16397886 |
D014801 | Vitamin A | RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of COL2A1 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16397886 |
D014801 | Vitamin A | RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of SOX9 mRNA] | affects cotreatment|decreases expression|decreases reaction | 16397886 |
D014801 | Vitamin A | RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS1 mRNA] | affects cotreatment|decreases reaction|increases expression | 16397886 |
D014801 | Vitamin A | RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16397886 |
D002762 | Cholecalciferol | RARA protein mutant form inhibits the reaction [[Cholecalciferol co-treated with TGFB1 protein] results in increased expression of CD14 mRNA] | affects cotreatment|decreases reaction|increases expression | 15988048 |
C111237 | vorinostat | decitabine promotes the reaction [vorinostat results in increased expression of RARA mRNA] | increases expression|increases reaction | 17417771 |
C111237 | vorinostat | vorinostat results in increased expression of RARA mRNA | increases expression | 17417771 |
D015032 | Zinc | Zinc results in increased expression of RARA protein mutant form | increases expression | 16330433 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 3.79 | 14745880 | |
MESH:D000014 | Abnormalities, Drug-Induced | Isotretinoin | 10.25 | 18769834 | |
MESH:D000014 | Abnormalities, Drug-Induced | Phenytoin | 10.25 | 10563481 9118846 3425630 6195326 9677735 8986270 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 10.25 | 14514962 15322242 11752688 | |
MESH:D000015 | Abnormalities, Multiple | Isotretinoin | 8.54 | 18769834 | |
MESH:D000015 | Abnormalities, Multiple | Vitamin A | 8.54 | 10992263 | |
MESH:D000138 | Acidosis | Ammonium Chloride | 2.82 | 18287403 | |
MESH:D017486 | Acneiform Eruptions | Isotretinoin | 5.53 | 16232082 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 9.50 | 17505938 | |
MESH:D000152 | Acne Vulgaris | Isotretinoin | 9.50 | 18769834 16185265 | |
MESH:D000169 | Acrodermatitis | Zinc | 4.66 | 16889938 17190629 17202136 | |
MESH:D058186 | Acute Kidney Injury | Cisplatin | 6.93 | 12690470 17670903 15814532 | |
MESH:D058186 | Acute Kidney Injury | Gentamicins | 6.93 | 11274264 | |
MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 3.35 | 11850527 18653653 | |
MESH:D000230 | Adenocarcinoma | arsenic trioxide | 16.82 | 19825857 11798837 | |
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 16.82 | 20464547 20127859 | |
MESH:D000230 | Adenocarcinoma | Cisplatin | 16.82 | 17638652 11798837 | |
MESH:D000230 | Adenocarcinoma | Estradiol | 16.82 | 11473722 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 16.82 | 14692618 | |
MESH:D000230 | Adenocarcinoma | Fenretinide | 16.82 | 10697514 | |
MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 16.82 | 15113128 15688392 | |
MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 12.07 | 3712494 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 12.07 | 6695378 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 12.07 | 10737359 6695378 | |
MESH:D000236 | Adenoma | Melatonin | 12.07 | 17195641 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 7.61 | 19061943 17620307 19052882 17162532 16434500 18056438 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 7.61 | 16835633 | |
MESH:D000419 | Albuminuria | Raloxifene | 3.89 | 17308373 17451421 | |
MESH:D019973 | Alcohol-Related Disorders | Curcumin | 11.12 | 17887948 | |
MESH:D019973 | Alcohol-Related Disorders | puerarin | 11.12 | 17887948 | |
MESH:D000505 | Alopecia | Tretinoin | 3.01 | 15955085 | |
MESH:D000544 | Alzheimer Disease | Curcumin | 5.35 | 15590663 | |
MESH:D000544 | Alzheimer Disease | Raloxifene | 5.35 | 15800139 | |
MESH:D000544 | Alzheimer Disease | Zinc | 5.35 | 16580781 17119284 16410023 16325427 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 6.82 | 11748828 | |
MESH:D000740 | Anemia | Vitamin A | 6.82 | 16960172 | |
MESH:D018798 | Anemia, Iron-Deficiency | Vitamin A | 4.14 | 16960172 | |
MESH:D000755 | Anemia, Sickle Cell | Zinc | 4.19 | 16916123 | |
MESH:D000987 | Antisocial Personality Disorder | Testosterone | 5.10 | 7506515 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.35 | 19183758 | |
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 2.75 | 11256880 | |
MESH:D001169 | Arthritis, Experimental | Dexamethasone | 9.35 | 17659584 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 9.35 | 15885639 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 9.35 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Am 80 | 6.16 | 16819260 | |
MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 6.16 | 16807698 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 6.16 | 16292516 | |
MESH:D001249 | Asthma | epigallocatechin gallate | 8.88 | 16516891 | |
MESH:D001249 | Asthma | Tretinoin | 8.88 | 16456186 | |
MESH:D001249 | Asthma | Vitamin A | 8.88 | 16732791 | |
MESH:D001249 | Asthma | Zinc | 8.88 | 17085522 | |
MESH:D050197 | Atherosclerosis | Am 80 | 8.50 | 16484594 | |
MESH:D050197 | Atherosclerosis | Curcumin | 8.50 | 18704882 | |
MESH:D050197 | Atherosclerosis | Phenytoin | 8.50 | 15136057 | |
MESH:D001321 | Autistic Disorder | Melatonin | 3.53 | 16919138 16897403 | |
MESH:D001327 | Autoimmune Diseases | Cholecalciferol | 14.10 | 16142846 | |
MESH:D001327 | Autoimmune Diseases | Curcumin | 14.10 | 19761891 | |
MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 14.10 | 19761891 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 3.69 | 16935849 | |
MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 4.26 | 1440618 11289319 | |
MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 11.48 | 16206674 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 11.48 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 11.48 | 16206674 16197459 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.04 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.25 | 15746008 | |
MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 4.13 | 14601052 | |
MESH:D001862 | Bone Resorption | bisphenol A | 3.20 | 11985600 | |
MESH:D001930 | Brain Injuries | Raloxifene | 8.73 | 16580743 | |
MESH:D001930 | Brain Injuries | Zinc | 8.73 | 17109824 | |
MESH:D002545 | Brain Ischemia | beta Carotene | 13.16 | 16157235 | |
MESH:D002545 | Brain Ischemia | Curcumin | 13.16 | 16770732 | |
MESH:D002545 | Brain Ischemia | puerarin | 13.16 | 16041641 | |
MESH:D001932 | Brain Neoplasms | Curcumin | 7.01 | 17596214 | |
MESH:D001932 | Brain Neoplasms | Fenretinide | 7.01 | 16187019 | |
MESH:D001943 | Breast Neoplasms | 4-(1H-imidazol-1-yl)retinoic acid | 16.76 | 17145897 17387344 | |
MESH:D001943 | Breast Neoplasms | alitretinoin | 16.76 | 16344269 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 16.76 | 20146248 17474063 | |
MESH:D001943 | Breast Neoplasms | bisphenol A | 16.76 | 17123778 | |
MESH:D001943 | Breast Neoplasms | Cisplatin | 16.76 | 18382427 19526202 | |
MESH:D001943 | Breast Neoplasms | Curcumin | 16.76 | 18593918 18462866 19250217 16243823 | |
MESH:D001943 | Breast Neoplasms | decitabine | 16.76 | 18320071 19208741 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 16.76 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Estradiol | 16.76 | 12948864 19861407 17018787 17289903 14630087 16675129 17261762 18497071 | |
MESH:D001943 | Breast Neoplasms | Fenretinide | 16.76 | 16601279 | |
MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 16.76 | 14633655 16253758 11306469 | |
MESH:D001943 | Breast Neoplasms | Raloxifene | 16.76 | 16912660 15758505 17595753 16837676 15775269 17261762 17440819 17049068 17242785 15572757 17952589 17893378 | |
MESH:D001943 | Breast Neoplasms | Retinoids | 16.76 | 17491551 19340624 17368321 | |
MESH:D001943 | Breast Neoplasms | Tamoxifen | 16.76 | 19487384 19115204 18351453 20544844 19059307 19189210 19066611 19288272 18984771 15668708 21138602 17261762 19244106 16202921 17242785 21152245 20065188 20859285 18821012 19200415 17440819 15565566 20005174 19221464 19289846 19189212 20135344 19011961 19410462 18629630 18425577 19084267 18997820 17893378 11161223 18855134 16818667 18815881 19103187 19155303 16873071 19142967 16273361 20390343 17049068 | |
MESH:D001943 | Breast Neoplasms | Testosterone | 16.76 | 17261762 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 16.76 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 16.76 | 16873071 16443354 16166294 | |
MESH:D001943 | Breast Neoplasms | vorinostat | 16.76 | 16144943 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 10.57 | 16813970 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Vitamin A | 10.57 | 17426644 17377406 | |
MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.64 | 11589617 | |
MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.72 | 16111702 | |
MESH:D002252 | Carbon Tetrachloride Poisoning | Melatonin | 4.60 | 15700767 | |
MESH:D002277 | Carcinoma | Curcumin | 6.28 | 18593918 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 6.28 | 16835633 | |
MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.78 | 19066611 | |
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 4.40 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | marker/mechanism | 18026104 | ||
MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 13.68 | 3581430 7296757 | |
MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 13.68 | 14691202 15553829 15073043 16217749 11135700 | |
MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 13.68 | 17982673 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 13.68 | 20007298 17428255 10672840 20727157 19335982 16502159 16878318 10737359 17761372 20214788 19919837 18978308 18506893 18665156 18393292 18785209 20514400 18971187 18210153 20512989 3581430 16830150 3084413 20935162 17138121 19418558 18788625 19394651 16288022 16935385 19539802 21159647 19052882 16698587 17978847 11831363 17173139 16779866 19171122 16540662 17055752 19519916 19701751 20432363 18494052 16569478 16681979 16328049 18691550 18056438 20524982 19208518 20101231 16807293 19822196 17162532 19383236 19107877 20084675 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 13.68 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 13.68 | 16270382 17159502 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 13.68 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 13.68 | 1917145 | |
MESH:D002278 | Carcinoma in Situ | bisphenol A | 4.25 | 17123778 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 4.69 | 12023789 16685392 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 4.69 | 18414057 | |
MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 4.12 | 19014326 | |
MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 2.27 | 7296757 | |
MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 3.46 | 12490120 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 24.43 | 20419170 | |
MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 24.43 | 17066447 18337622 6189445 | |
MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 24.43 | 18462866 | |
MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 24.43 | 19215824 | |
MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 24.43 | 16274795 | |
MESH:D002294 | Carcinoma, Squamous Cell | Isotretinoin | 24.43 | 11237771 | |
MESH:D002294 | Carcinoma, Squamous Cell | retinol palmitate | 24.43 | 15984520 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 24.43 | 16051514 16096774 | |
MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 24.43 | 16543248 | |
MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 7.33 | 17572228 | |
MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 7.33 | 17572228 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 1.91 | 18850075 18670907 16120746 | |
MESH:D002318 | Cardiovascular Diseases | Raloxifene | 5.82 | 15775269 | |
MESH:D002318 | Cardiovascular Diseases | Zinc | 5.82 | 16936243 | |
MESH:D002386 | Cataract | Am 580 | 9.84 | 17460283 | |
MESH:D002386 | Cataract | Methylnitrosourea | 9.84 | 12484553 | |
MESH:D002386 | Cataract | Tretinoin | 9.84 | 17460283 | |
MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 11.61 | 7505956 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 11.61 | 21159647 17174075 2727394 7505956 | |
MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 11.61 | 18566989 | |
MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 11.61 | 7505956 2727394 | |
MESH:D002493 | Central Nervous System Diseases | Phenytoin | 4.57 | 4080065 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 10.52 | 16154183 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 10.52 | 16129372 | |
MESH:D002659 | Child Development Disorders, Pervasive | Testosterone | 3.35 | 20678186 | |
MESH:D015362 | Child Nutrition Disorders | Vitamin A | 4.72 | 16153327 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 7.21 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 7.21 | 16835633 | |
MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 10.24 | 9022650 19486331 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 10.24 | 15861022 17681005 17110522 16105132 17333356 11677210 16919318 | |
MESH:D002779 | Cholestasis | Vitamin A | 10.24 | 16175620 | |
OMIM:601042 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | Phenytoin | 5.13 | 11748493 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 4.40 | 16461808 | |
MESH:D002971 | Cleft Lip | Phenytoin | 3.71 | 2227380 | |
MESH:D002972 | Cleft Palate | Phenytoin | 11.03 | 3877104 2227380 6862529 10789828 6856622 1687470 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 11.03 | 15668235 8697196 12621046 15340226 16354765 | |
MESH:D002972 | Cleft Palate | Tretinoin | 11.03 | 9407595 | |
MESH:D002972 | Cleft Palate | Vitamin A | 11.03 | 16054864 | |
MESH:D003072 | Cognition Disorders | Raloxifene | 3.90 | 15800139 | |
MESH:D003092 | Colitis | Am 580 | 12.06 | 17035595 | |
MESH:D003092 | Colitis | Curcumin | 12.06 | 16804969 18200517 16782535 | |
MESH:D003092 | Colitis | Tretinoin | 12.06 | 17035595 | |
MESH:D003103 | Coloboma | Curcumin | 9.10 | 18809619 | |
MESH:D003103 | Coloboma | Phenytoin | 9.10 | 9212184 | |
MESH:D003110 | Colonic Neoplasms | Butyrates | 11.37 | 15936596 | |
MESH:D003110 | Colonic Neoplasms | Curcumin | 11.37 | 16340194 19359593 | |
MESH:D003110 | Colonic Neoplasms | decitabine | 11.37 | 17616700 | |
MESH:D003110 | Colonic Neoplasms | Deoxycholic Acid | 11.37 | 16213893 | |
MESH:D003110 | Colonic Neoplasms | Dexamethasone | 11.37 | 15824018 | |
MESH:D003110 | Colonic Neoplasms | Vitamin A | 11.37 | 17219422 16267017 | |
MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 5.29 | 20501625 | |
MESH:D015179 | Colorectal Neoplasms | Cisplatin | 5.29 | 15273666 | |
MESH:D015179 | Colorectal Neoplasms | decitabine | 5.29 | 18981723 | |
MESH:D015179 | Colorectal Neoplasms | Fenretinide | 5.29 | 17273769 | |
MESH:D015179 | Colorectal Neoplasms | Polychlorinated Biphenyls | 5.29 | 15531428 | |
MESH:D000013 | Congenital Abnormalities | Phenytoin | 7.27 | 10627286 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 7.27 | 14669216 17141729 | |
MESH:D016510 | Corneal Neovascularization | Curcumin | 4.17 | 18497527 | |
MESH:D023903 | Coronary Restenosis | arsenic trioxide | 3.48 | 12609071 | |
MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 14.16 | 10525206 | |
MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 14.16 | 17728286 | |
MESH:D019465 | Craniofacial Abnormalities | Isotretinoin | 14.16 | 18769834 9879862 | |
MESH:D019465 | Craniofacial Abnormalities | nitrofen | 14.16 | 11405365 | |
MESH:D019465 | Craniofacial Abnormalities | Phenytoin | 14.16 | 8986270 19952982 9212184 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 14.16 | 15322242 20055451 10048152 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 14.16 | 16925845 9211117 9142499 8800419 9125849 9664655 14991402 9224671 10589399 17551590 | |
MESH:D019465 | Craniofacial Abnormalities | Vitamin A | 14.16 | 10992263 | |
MESH:D019465 | Craniofacial Abnormalities | Zinc | 14.16 | 19302082 | |
MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 3.41 | 15213294 | |
MESH:D003704 | Dementia | Polychlorinated Biphenyls | 4.03 | 16140633 | |
MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.64 | 19031437 | |
MESH:D003865 | Depressive Disorder, Major | Raloxifene | 3.52 | 17474826 | |
MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 7.66 | 8156756 12868966 18759878 8970840 2524372 11298694 11906362 14531868 | |
MESH:D017449 | Dermatitis, Allergic Contact | cobaltous chloride | 7.66 | 11298694 15059100 16823706 | |
MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 7.66 | 12438553 | |
MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 2.81 | 2952479 3621924 | |
MESH:D003920 | Diabetes Mellitus | Zinc | 3.57 | 16479319 | |
MESH:D003921 | Diabetes Mellitus, Experimental | vanadyl sulfate | 3.76 | 16684804 | |
MESH:D003922 | Diabetes Mellitus, Type 1 | Vitamin A | 3.23 | 16506275 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 8.16 | 18403477 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 8.16 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 8.16 | 16988119 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 8.16 | 17107852 | |
MESH:D003928 | Diabetic Nephropathies | Curcumin | 16.24 | 18204486 | |
MESH:D003928 | Diabetic Nephropathies | Estradiol | 16.24 | 19279558 | |
MESH:D003928 | Diabetic Nephropathies | Raloxifene | 16.24 | 17308373 17451421 15920148 | |
MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 16.24 | 19279558 | |
MESH:D003967 | Diarrhea | Dexamethasone | 6.23 | 7237001 | |
MESH:D003967 | Diarrhea | vorinostat | 6.23 | 20479100 | |
OMIM:607208 | DRAVET SYNDROME | Phenytoin | 4.67 | 11748493 | |
MESH:D003875 | Drug Eruptions | Phenytoin | 4.78 | 15024534 | |
MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 6.63 | 11289319 16192314 6482804 9022650 18289764 7440962 18692083 18648102 9328219 8291058 6679447 1440618 9653073 | |
MESH:D056486 | Drug-Induced Liver Injury | Chlorpromazine | 6.63 | 11461765 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 6.63 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 6.63 | 20420201 | |
MESH:D004362 | Drug Toxicity | Cisplatin | 10.55 | 12649298 12231392 19839026 15033597 | |
MESH:D004362 | Drug Toxicity | Gentamicins | 10.55 | 15033597 11033412 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 10.55 | 11462148 | |
MESH:D015352 | Dry Eye Syndromes | Vitamin A | 5.06 | 16146918 | |
MESH:D004381 | Duodenal Ulcer | Curcumin | 3.35 | 17351913 | |
MESH:D050171 | Dyslipidemias | Fenofibrate | 3.86 | 16707586 | |
MESH:C538011 | Eales disease | Vitamin A | 4.87 | 9068938 | |
MESH:D004480 | Ectromelia | Vitamin A | 5.07 | 16054864 | |
MESH:D004485 | Eczema | Dexamethasone | 3.76 | 12438553 | |
MESH:D004487 | Edema | Dexamethasone | 7.77 | 19703484 | |
MESH:D004487 | Edema | Raloxifene | 7.77 | 15860553 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 7.77 | 12711302 11000095 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 9.44 | 18230668 15322242 16714409 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 9.44 | 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Am 80 | 21.37 | 16819260 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 21.37 | 12538720 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Phenytoin | 21.37 | 17654737 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 21.37 | 15845917 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 21.37 | 19031437 | |
MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 11.53 | 19294695 | |
MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 11.53 | 19294695 | |
MESH:D016889 | Endometrial Neoplasms | Estradiol | 13.51 | 11473722 18566989 19148513 | |
MESH:D016889 | Endometrial Neoplasms | Fenofibrate | 13.51 | 16569247 | |
MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 13.51 | 16202921 17893378 19155303 20544844 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 13.51 | 16569247 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.37 | 10568697 9294722 | |
MESH:D019446 | Endotoxemia | Lipopolysaccharides | 3.66 | 15821434 17637181 15328337 | |
MESH:D004816 | Epidermal Necrolysis, Toxic | Phenytoin | 4.49 | 20235791 | |
MESH:D004820 | Epidermolysis Bullosa | Phenytoin | 5.48 | 1399206 6251365 | |
MESH:D004828 | Epilepsies, Partial | Phenytoin | 4.17 | 17116037 11558140 | |
MESH:D004827 | Epilepsy | Phenytoin | 3.51 | 821787 11434505 20417680 | |
MESH:D017029 | Epilepsy, Complex Partial | Phenytoin | 4.57 | 7750514 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Phenytoin | 4.33 | 3659116 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 4.36 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 10.98 | 3581430 | |
MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 10.98 | 12903497 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 10.98 | 16530937 | |
MESH:D004938 | Esophageal Neoplasms | Cisplatin | 10.98 | 16481741 15173087 16785472 17638652 15464296 | |
MESH:D004938 | Esophageal Neoplasms | Zinc | 10.98 | 16543248 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 6.91 | 11564622 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 6.91 | 16938888 9664655 | |
MESH:D015785 | Eye Diseases, Hereditary | Retinoids | 5.27 | 16968212 | |
MESH:D005221 | Fatigue | vorinostat | 4.86 | 20479100 | |
MESH:D005234 | Fatty Liver | arsenic trioxide | 22.16 | 15073043 | |
MESH:D005234 | Fatty Liver | Curcumin | 22.16 | 19297423 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 22.16 | 21071580 20387270 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 22.16 | 15345470 | |
MESH:D005234 | Fatty Liver | Raloxifene | 22.16 | 17473493 | |
MESH:D005234 | Fatty Liver | Tamoxifen | 22.16 | 19224547 14986274 | |
MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.74 | 16709447 | |
MESH:D005313 | Fetal Death | Phenytoin | 8.34 | 10627286 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 8.34 | 11858732 | |
MESH:D005327 | Fetal Resorption | Vitamin A | 4.61 | 16054864 | |
MESH:D005334 | Fever | Lipopolysaccharides | 3.37 | 11852909 9205823 | |
MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 4.26 | 6705139 | |
MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 3.79 | 14745880 | |
MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 3.44 | 19069698 | |
MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 4.49 | 11555667 | |
MESH:D005355 | Fibrosis | Curcumin | 10.69 | 18705752 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 10.69 | 20067830 | |
MESH:D005355 | Fibrosis | Tretinoin | 10.69 | 17994277 | |
MESH:D005391 | Firesetting Behavior | Testosterone | 5.10 | 7506515 | |
MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.56 | 16904648 | |
MESH:D005756 | Gastritis | Zinc | 4.05 | 17241300 | |
MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.97 | 18462866 | |
MESH:D005885 | Gingival Hyperplasia | Phenytoin | 4.92 | 9029455 | |
MESH:D019214 | Gingival Overgrowth | Phenytoin | 5.48 | 16390469 14659971 | |
MESH:D005909 | Glioblastoma | Curcumin | 21.02 | 17596214 | |
MESH:D005909 | Glioblastoma | Fenretinide | 21.02 | 16187019 | |
MESH:D005909 | Glioblastoma | Okadaic Acid | 21.02 | 17312396 | |
MESH:D005909 | Glioblastoma | Testosterone | 21.02 | 17162496 | |
MESH:D005909 | Glioblastoma | Tretinoin | 21.02 | 17312396 | |
MESH:D005909 | Glioblastoma | trichostatin A | 21.02 | 18801729 | |
MESH:D005910 | Glioma | Methylnitrosourea | 3.21 | 9825942 | |
MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 3.35 | 7505956 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.84 | 10696789 | |
MESH:D006130 | Growth Disorders | Zinc | 3.44 | 17217573 | |
MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 23.23 | 15102660 15464296 | |
MESH:D006258 | Head and Neck Neoplasms | Curcumin | 23.23 | 18462866 18829502 | |
MESH:D006258 | Head and Neck Neoplasms | decitabine | 23.23 | 19215824 | |
MESH:D006258 | Head and Neck Neoplasms | Retinoids | 23.23 | 17368321 | |
MESH:D006258 | Head and Neck Neoplasms | retinol palmitate | 23.23 | 15984520 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 23.23 | 16096774 | |
MESH:D034381 | Hearing Loss | Cisplatin | 8.17 | 19898482 | |
MESH:D034381 | Hearing Loss | Gentamicins | 8.17 | 19130971 17868369 18024279 15968427 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 4.40 | 16084493 | |
MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.79 | 15464296 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 16.31 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | nitrofen | 16.31 | 16080930 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 16.31 | 10048152 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 16.31 | 14991402 9664655 | |
MESH:D006330 | Heart Defects, Congenital | Vitamin A | 16.31 | 16080930 10992263 | |
MESH:D006331 | Heart Diseases | Raloxifene | 3.00 | 11110106 | |
MESH:D006333 | Heart Failure | Zinc | 3.12 | 17162251 | |
MESH:D006335 | Heart Injuries | Zinc | 5.01 | 17074742 | |
MESH:D016481 | Helicobacter Infections | Zinc | 3.85 | 17241300 | |
MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.73 | 16366002 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.67 | 11000095 | |
MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 2.82 | 6705139 | |
MESH:D006527 | Hepatolenticular Degeneration | Zinc | 3.97 | 17276780 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 2.19 | 12621046 15340226 16120746 | |
MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 4.31 | 17701891 | |
MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 7.94 | 7520565 | |
MESH:D006548 | Hernia, Diaphragmatic | nitrofen | 7.94 | 12407540 10359170 15578192 17270546 10370016 12746050 15185205 12194112 11051153 10370017 10898224 15136996 10693666 18280291 17618886 17245593 16720372 12505043 11409163 9476886 11057544 9575882 9473106 7760232 12904592 16863852 9698600 16292651 12021965 7576705 15756563 15793718 12759764 10541330 18958481 10898222 7520565 15088113 18280292 11076806 11584395 11685700 11329586 15764645 9859898 15707848 10646786 16490937 8863223 16473863 16080930 11588001 12547725 | |
MESH:D006548 | Hernia, Diaphragmatic | Vitamin A | 7.94 | 16877224 16863852 15707848 16490937 16292552 17436238 | |
MESH:D006558 | Herpes Genitalis | Estradiol | 4.28 | 15709030 | |
MESH:D006561 | Herpes Simplex | Chlorpromazine | 4.56 | 1682908 | |
MESH:D006628 | Hirsutism | Testosterone | 4.90 | 17019078 | |
MESH:D015658 | HIV Infections | beta Carotene | 5.80 | 16960176 | |
MESH:D015658 | HIV Infections | Vitamin A | 5.80 | 16960176 | |
MESH:D006679 | HIV Seropositivity | Vitamin A | 4.86 | 17209195 | |
MESH:D006689 | Hodgkin Disease | Cisplatin | 2.99 | 16200630 16170182 | |
MESH:D019584 | Hot Flashes | Estradiol | 3.01 | 17088409 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.29 | 8697196 18606429 16354765 15340226 16959395 | |
MESH:D006930 | Hyperalgesia | Alendronate | 6.37 | 16769263 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 6.37 | 16870215 | |
MESH:D017588 | Hyperandrogenism | Testosterone | 4.55 | 17019078 | |
MESH:D053565 | Hypercalciuria | Gentamicins | 4.97 | 17652376 | |
MESH:D006937 | Hypercholesterolemia | Curcumin | 3.39 | 18704882 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.84 | 16778211 | |
MESH:D020138 | Hyperhomocysteinemia | Phenytoin | 4.04 | 10459572 | |
MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 3.22 | 15034207 | |
MESH:D006973 | Hypertension | Dexamethasone | 6.64 | 17042910 | |
MESH:D006973 | Hypertension | Raloxifene | 6.64 | 17577099 15787275 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 6.64 | 18670907 18850075 | |
MESH:D006986 | Hypervitaminosis A | Vitamin A | 5.41 | 16054864 | |
MESH:D007006 | Hypogonadism | Testosterone | 4.03 | 12002444 | |
MESH:D007018 | Hypopituitarism | Testosterone | 5.45 | 17426086 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 3.09 | 16945680 16569931 | |
MESH:D007174 | Impulse Control Disorders | Testosterone | 5.10 | 7506515 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.78 | 12013081 | |
MESH:D007248 | Infertility, Male | decitabine | 8.26 | 17581917 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 8.26 | 17937319 | |
MESH:D007248 | Infertility, Male | Methylnitrosourea | 8.26 | 7193160 | |
MESH:D007249 | Inflammation | Curcumin | 14.21 | 16956363 17151092 18403477 | |
MESH:D007249 | Inflammation | Dexamethasone | 14.21 | 11099482 8960868 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 14.21 | 18785209 | |
MESH:D007249 | Inflammation | Lipopolysaccharides | 14.21 | 17237260 17963957 12878042 9205823 17255318 | |
MESH:D007249 | Inflammation | Tamoxifen | 14.21 | 19457130 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 14.21 | 12200463 12878042 | |
MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 2.85 | 18596194 18200517 | |
MESH:D007333 | Insulin Resistance | bisphenol A | 5.69 | 16393666 | |
MESH:D007333 | Insulin Resistance | Estradiol | 5.69 | 16393666 16627594 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 3.05 | 17994277 | |
MESH:D007414 | Intestinal Neoplasms | caffeic acid phenethyl ester | 7.93 | 10783313 | |
MESH:D007414 | Intestinal Neoplasms | Curcumin | 7.93 | 10783313 | |
MESH:D019586 | Intracranial Hypertension | Vitamin A | 5.07 | 15955940 | |
MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 3.94 | 17255318 | |
MESH:D007511 | Ischemia | Zinc | 3.91 | 16584753 | |
MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 4.26 | 8074119 9022650 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 7.71 | 16580747 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 7.71 | 15992940 17551590 | |
MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 4.90 | 16144296 | |
MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 10.82 | 15464296 | |
MESH:D007673 | Kidney Cortex Necrosis | Gentamicins | 10.82 | 18842672 | |
MESH:D007674 | Kidney Diseases | caffeic acid phenethyl ester | 14.05 | 15369732 | |
MESH:D007674 | Kidney Diseases | Cisplatin | 14.05 | 19839026 12649298 12231392 15190930 18289764 | |
MESH:D007674 | Kidney Diseases | Estradiol | 14.05 | 15618244 | |
MESH:D007674 | Kidney Diseases | Gentamicins | 14.05 | 17934191 18289764 19349640 | |
MESH:D007674 | Kidney Diseases | Zinc | 14.05 | 16960431 | |
MESH:D007676 | Kidney Failure, Chronic | Zinc | 3.75 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 8.86 | 6582329 | |
MESH:D007680 | Kidney Neoplasms | Estradiol | 8.86 | 15610895 | |
MESH:D007680 | Kidney Neoplasms | Tamoxifen | 8.86 | 18625569 | |
MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 9.51 | 11231351 | |
MESH:D007683 | Kidney Tubular Necrosis, Acute | Gentamicins | 9.51 | 11231351 | |
MESH:D007889 | Leiomyoma | Curcumin | 8.87 | 18555241 | |
MESH:D007889 | Leiomyoma | Raloxifene | 8.87 | 16973256 | |
MESH:D016773 | Leishmaniasis, Cutaneous | Gentamicins | 3.85 | 10219319 | |
MESH:D007898 | Leishmaniasis, Visceral | Antimony Potassium Tartrate | 3.98 | 12707265 | |
MESH:D007938 | Leukemia | arsenic trioxide | 11.43 | 15070760 | |
MESH:D007938 | Leukemia | Curcumin | 11.43 | 18462866 | |
MESH:D007938 | Leukemia | decitabine | 11.43 | 19235587 18980019 | |
MESH:D007938 | Leukemia | Tretinoin | 11.43 | 17143497 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 7.54 | 12560223 17077332 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 7.54 | 16106398 | |
MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 3.57 | 16972261 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 2.86 | 14633726 | |
MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 22.88 | 19077051 | |
MESH:D007951 | Leukemia, Myeloid | decitabine | 22.88 | 18454857 19117987 17236224 | |
MESH:D007951 | Leukemia, Myeloid | Hydroxyurea | 22.88 | 16532439 | |
MESH:D007951 | Leukemia, Myeloid | Retinoids | 22.88 | 16482212 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 22.88 | 16482212 16932348 19285840 | |
MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 9.53 | 20471514 16968895 16467208 17050201 19850784 | |
MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trisulfide | 9.53 | 17708794 | |
MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 9.53 | 18704418 19387464 18206229 17679729 18460780 19010910 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 9.53 | 17596541 19850784 16294345 | |
MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 9.53 | 18206229 | |
MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.71 | 18055864 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | marker/mechanism | 17649720 17712046 16239915 16788101 16835227 16935935 19029980 19035177 17294898 14706140 16891316 | ||
MESH:D015473 | Leukemia, Promyelocytic, Acute | Am 80 | 27.78 | 16531727 16819260 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Antimony Potassium Tartrate | 27.78 | 9834237 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | antimony trioxide | 27.78 | 9834237 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 27.78 | 11161223 16112521 19642359 15622746 17107899 15748426 19035177 9834237 17649720 16331271 12712474 12018890 19225113 12679006 16966277 16330433 16823087 17869043 16891316 17217047 15213294 11468182 17712046 15336539 19075265 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | caffeic acid phenethyl ester | 27.78 | 16766008 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Thiophenes | 27.78 | 16140955 16140954 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 27.78 | 17506722 16331271 12679006 17217047 17361223 16140955 16788101 17368321 17107899 9834237 19642359 15748426 16823087 19029980 17649720 19035177 19075265 16766008 17294898 16935935 17712046 17301526 19225113 16891316 17339181 | |
MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 9.37 | 16882451 | |
MESH:D015458 | Leukemia, T-Cell | Curcumin | 9.37 | 16106398 | |
MESH:D007970 | Leukopenia | Lipopolysaccharides | 3.96 | 15821434 | |
MESH:D007972 | Leukoplakia, Oral | Fenretinide | 5.29 | 16707609 | |
MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 10.63 | 15526292 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 10.63 | 9224671 | |
MESH:D017880 | Limb Deformities, Congenital | Vitamin A | 10.63 | 16054864 | |
MESH:D008064 | Lipidoses | Chlorpromazine | 6.51 | 17567588 15342952 | |
MESH:D008064 | Lipidoses | Tamoxifen | 6.51 | 15342952 17567588 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 8.73 | 18665156 18407596 20032147 19638242 18522880 | |
MESH:D008103 | Liver Cirrhosis | puerarin | 8.73 | 16426832 | |
MESH:D008103 | Liver Cirrhosis | Vitamin A | 8.73 | 16256175 | |
MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 2.69 | 9327722 15034207 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 17.27 | 18006644 17355460 18705752 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 17.27 | 16718785 | |
MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 17.27 | 17481882 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 17.27 | 14659978 14716833 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Fenofibrate | 17.27 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 17.27 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Melatonin | 17.27 | 16703270 15298665 15925388 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 17.27 | 18564211 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 17.27 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 17.27 | 18397230 16248980 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin A | 17.27 | 16248980 | |
MESH:D008107 | Liver Diseases | Chlorpromazine | 12.41 | 14986274 | |
MESH:D008107 | Liver Diseases | Curcumin | 12.41 | 16956363 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 12.41 | 17034775 | |
MESH:D008107 | Liver Diseases | limonene | 12.41 | 1715830 | |
MESH:D008107 | Liver Diseases | Phenytoin | 12.41 | 14986274 | |
MESH:D008107 | Liver Diseases | Vitamin A | 12.41 | 16175620 | |
MESH:D008108 | Liver Diseases, Alcoholic | Vitamin A | 4.43 | 16762690 | |
MESH:D008113 | Liver Neoplasms | arsenic trioxide | 13.39 | 14682389 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 13.39 | 21137059 20195826 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 13.39 | 18754104 9163691 12112319 18648771 19690152 20118626 19427195 19254457 19426721 18978307 21278145 21071580 20452335 19850985 16942905 20434301 19812893 19551842 20137499 19256749 12771043 2422723 19499222 19642983 19833225 2862719 19638242 19090486 18644402 19073162 21047994 20101389 18977376 20405173 15175105 19996281 15885732 10737359 20492335 20583210 19255062 19294768 21167192 20501860 | |
MESH:D008113 | Liver Neoplasms | Fenofibrate | 13.39 | 18978307 | |
MESH:D008113 | Liver Neoplasms | Tamoxifen | 13.39 | 16684651 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 13.39 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 32.54 | 1399818 6587162 598648 3712494 | |
MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 32.54 | 20377131 | |
MESH:D008114 | Liver Neoplasms, Experimental | beta Carotene | 32.54 | 17113696 | |
MESH:D008114 | Liver Neoplasms, Experimental | Deoxycholic Acid | 32.54 | 6150874 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 32.54 | 18079962 21159647 19539802 17942915 18544905 18282651 3124819 18164116 19126423 17854601 19009564 2563599 18093689 19519916 16267830 18253720 18775883 18308698 19004024 16842330 9362446 17174075 | |
MESH:D008114 | Liver Neoplasms, Experimental | Fenofibrate | 32.54 | 18775883 18253720 | |
MESH:D008114 | Liver Neoplasms, Experimental | kojic acid | 32.54 | 18544905 | |
MESH:D008114 | Liver Neoplasms, Experimental | Polychlorinated Biphenyls | 32.54 | 1423854 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 32.54 | 12151625 | |
MESH:D008114 | Liver Neoplasms, Experimental | Vitamin A | 32.54 | 17113696 | |
MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.77 | 15213294 | |
MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 4.74 | 16080182 | |
MESH:D008171 | Lung Diseases | nitrofen | 6.46 | 16863852 9614859 17245593 9859898 | |
MESH:D008171 | Lung Diseases | Vitamin A | 6.46 | 16863852 | |
MESH:D055370 | Lung Injury | Lipopolysaccharides | 3.30 | 21114838 | |
MESH:D008175 | Lung Neoplasms | alitretinoin | 21.80 | 16413115 | |
MESH:D008175 | Lung Neoplasms | arsenic trioxide | 21.80 | 11798837 19825857 | |
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 21.80 | 17053015 20869020 20464547 20064080 18520028 6695378 20135361 18816296 18569708 | |
MESH:D008175 | Lung Neoplasms | beta Carotene | 21.80 | 16401635 | |
MESH:D008175 | Lung Neoplasms | Cisplatin | 21.80 | 17225452 11798837 6189445 | |
MESH:D008175 | Lung Neoplasms | Curcumin | 21.80 | 19359593 16243823 18462866 | |
MESH:D008175 | Lung Neoplasms | Dexamethasone | 21.80 | 15824018 11195469 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 21.80 | 20512841 20970405 6695378 21163286 | |
MESH:D008175 | Lung Neoplasms | Isotretinoin | 21.80 | 15899809 | |
MESH:D008175 | Lung Neoplasms | Melatonin | 21.80 | 17195641 | |
MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 21.80 | 18062963 | |
MESH:D008175 | Lung Neoplasms | Tamoxifen | 21.80 | 18625569 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 21.80 | 11884234 19555203 | |
MESH:D008180 | Lupus Erythematosus, Systemic | Melatonin | 3.65 | 16373423 | |
MESH:D008223 | Lymphoma | Curcumin | 9.49 | 18462866 | |
MESH:D008223 | Lymphoma | decitabine | 9.49 | 19470736 | |
MESH:D008223 | Lymphoma | Methylnitrosourea | 9.49 | 16257854 11418001 | |
MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 4.09 | 14633661 | |
MESH:D016399 | Lymphoma, T-Cell | Curcumin | 3.97 | 16173963 | |
MESH:D016410 | Lymphoma, T-Cell, Cutaneous | vorinostat | 4.96 | 20479100 | |
MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 3.03 | 19428831 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 13.39 | 11408345 11807958 17203775 16891317 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 13.39 | 10697514 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 13.39 | 15313902 14633655 10767621 16827153 15113128 19196723 11751437 17020996 16619500 12931682 11807958 16944150 10838139 17131329 15688392 16051031 14999141 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 13.39 | 19196723 11731420 19196722 14580682 16827153 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 13.39 | 12773700 | |
MESH:D020149 | Manganese Poisoning | Estradiol | 10.15 | 19453300 | |
MESH:D020149 | Manganese Poisoning | Tamoxifen | 10.15 | 19453300 | |
MESH:D008415 | Mastocytosis | Retinoids | 5.84 | 16953078 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 2.43 | 17453147 | |
MESH:D008545 | Melanoma | Cisplatin | 17.60 | 17761969 16432458 16248763 16809738 18332650 18505091 12374674 17023156 12883367 15577323 12393984 18176117 11135225 | |
MESH:D008545 | Melanoma | Curcumin | 17.60 | 17885582 18462866 | |
MESH:D008545 | Melanoma | decitabine | 17.60 | 17785578 16505122 | |
MESH:D008545 | Melanoma | epigallocatechin gallate | 17.60 | 17992120 11746506 | |
MESH:D008545 | Melanoma | Fenretinide | 17.60 | 16270382 | |
MESH:D008545 | Melanoma | Isotretinoin | 17.60 | 17237267 | |
MESH:D008545 | Melanoma | Tamoxifen | 17.60 | 19393235 12393984 | |
MESH:D008545 | Melanoma | Tretinoin | 17.60 | 16752155 | |
MESH:D008545 | Melanoma | trichostatin A | 17.60 | 16505122 | |
MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 9.06 | 15990972 | |
MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 9.06 | 15990972 | |
MESH:D008569 | Memory Disorders | Curcumin | 3.46 | 17263510 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 3.70 | 16940565 | |
MESH:D001523 | Mental Disorders | Chlorpromazine | 4.03 | 16856516 | |
MESH:D008607 | Mental Retardation | Phenytoin | 3.36 | 9212184 | |
MESH:D008654 | Mesothelioma | Cisplatin | 5.89 | 17638057 | |
MESH:D008654 | Mesothelioma | hexamethylene bisacetamide | 5.89 | 15543656 | |
MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 4.80 | 15863610 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 6.82 | 16381670 | |
MESH:D009062 | Mouth Neoplasms | Fenretinide | 6.82 | 16274795 | |
MESH:D009101 | Multiple Myeloma | Am 80 | 30.18 | 17229644 | |
MESH:D009101 | Multiple Myeloma | arsenic trioxide | 30.18 | 14977855 15949261 19417148 11468182 19549372 | |
MESH:D009101 | Multiple Myeloma | Curcumin | 30.18 | 19372569 | |
MESH:D009101 | Multiple Myeloma | decitabine | 30.18 | 18172295 | |
MESH:D009101 | Multiple Myeloma | Dexamethasone | 30.18 | 15867202 15744524 16118317 | |
MESH:D009101 | Multiple Myeloma | Raloxifene | 30.18 | 16497877 | |
MESH:D009101 | Multiple Myeloma | trichostatin A | 30.18 | 18172295 | |
MESH:D009101 | Multiple Myeloma | Vitamin A | 30.18 | 16374440 | |
MESH:D009103 | Multiple Sclerosis | 4-Aminopyridine | 5.10 | 19915712 | |
MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 10.19 | 17962980 | |
MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 10.19 | 17962980 | |
MESH:D009137 | Muscular Dystrophy, Animal | Gentamicins | 5.52 | 18694830 | |
MESH:D009175 | Mycoplasma Infections | Chlorpromazine | 5.24 | 10773494 | |
MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.92 | 18349030 | |
MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 13.67 | 16882451 16105982 | |
MESH:D009190 | Myelodysplastic Syndromes | decitabine | 13.67 | 19010910 16882708 18608210 19157545 | |
MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 13.67 | 9809623 | |
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 13.67 | 17596541 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.41 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 2.69 | 16810080 | |
MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenytoin | 4.78 | 17484760 | |
MESH:D009224 | Myotonia Congenita | Phenytoin | 4.67 | 1896199 | |
MESH:D009232 | Myxoma | Raloxifene | 4.80 | 16343187 | |
MESH:D009325 | Nausea | vorinostat | 4.77 | 20479100 | |
MESH:D009336 | Necrosis | Melatonin | 4.73 | 12195237 | |
MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 7.99 | 16624393 | |
MESH:D009361 | Neoplasm Invasiveness | Curcumin | 7.99 | 18495463 | |
MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 7.32 | 3581430 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 7.32 | 3581430 9029167 | |
MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 7.32 | 19393235 | |
MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 2.22 | 19410462 | |
MESH:D009369 | Neoplasms | alitretinoin | 20.87 | 16946489 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 20.87 | 11141357 | |
MESH:D009369 | Neoplasms | beta Carotene | 20.87 | 17051425 | |
MESH:D009369 | Neoplasms | Cisplatin | 20.87 | 16773208 | |
MESH:D009369 | Neoplasms | decitabine | 20.87 | 19116145 17925555 19470736 | |
MESH:D009369 | Neoplasms | Fenretinide | 20.87 | 15958647 17353921 | |
MESH:D009369 | Neoplasms | Methylnitrosourea | 20.87 | 15533788 | |
MESH:D009369 | Neoplasms | Tretinoin | 20.87 | 16594593 16946489 | |
MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 3.76 | 12696579 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 8.35 | 12497104 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 8.35 | 19189210 19196722 19200415 | |
MESH:D009389 | Neovascularization, Pathologic | Estradiol | 3.00 | 17289903 | |
MESH:D009395 | Nephritis, Interstitial | Cisplatin | 3.74 | 15464296 | |
MESH:D009421 | Nervous System Malformations | bisphenol A | 17.69 | 16427766 11399458 | |
MESH:D009421 | Nervous System Malformations | Estradiol | 17.69 | 16427766 11399458 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 17.69 | 14600291 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 17.69 | 9125849 | |
MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.87 | 18462866 | |
MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 17.25 | 6679447 | |
MESH:D009436 | Neural Tube Defects | arsenic trioxide | 17.25 | 10525206 | |
MESH:D009436 | Neural Tube Defects | Phenytoin | 17.25 | 9118846 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 17.25 | 9142499 | |
MESH:D009436 | Neural Tube Defects | Vitamin A | 17.25 | 17400914 | |
MESH:D009442 | Neurilemmoma | Methylnitrosourea | 4.75 | 11555667 | |
MESH:D009447 | Neuroblastoma | Cisplatin | 5.96 | 8761367 | |
MESH:D009447 | Neuroblastoma | Isotretinoin | 5.96 | 17368321 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 2.73 | 20387270 | |
MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 3.96 | 8761367 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 4.36 | 20387270 | |
MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.94 | 16303764 | |
MESH:D009765 | Obesity | Curcumin | 2.52 | 19297423 | |
MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 2.77 | 6482804 4026338 | |
MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 4.26 | 3988306 | |
MESH:D010018 | Osteomalacia | Phenytoin | 4.67 | 17016548 | |
MESH:D010024 | Osteoporosis | Alendronate | 9.21 | 17882678 | |
MESH:D010024 | Osteoporosis | Curcumin | 9.21 | 18719352 | |
MESH:D010024 | Osteoporosis | Raloxifene | 9.21 | 17882678 15775268 19059307 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 3.54 | 17823083 15579764 17893378 15758505 | |
MESH:D010033 | Otitis Media | retinol palmitate | 6.13 | 17303254 | |
MESH:D010049 | Ovarian Diseases | bisphenol A | 4.25 | 11985600 | |
MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 21.69 | 12452020 19769630 16624393 | |
MESH:D010051 | Ovarian Neoplasms | Cisplatin | 21.69 | 15464296 19769630 6897625 17225452 | |
MESH:D010051 | Ovarian Neoplasms | Curcumin | 21.69 | 19020741 18462866 | |
MESH:D010051 | Ovarian Neoplasms | decitabine | 21.69 | 19331143 19259094 | |
MESH:D010051 | Ovarian Neoplasms | Estradiol | 21.69 | 19401270 | |
MESH:D010051 | Ovarian Neoplasms | Fenretinide | 21.69 | 16133793 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 21.69 | 16936753 | |
MESH:D010051 | Ovarian Neoplasms | trichostatin A | 21.69 | 19331143 | |
MESH:D010146 | Pain | Phenytoin | 5.17 | 15215642 | |
MESH:D010146 | Pain | Tretinoin | 5.17 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 27.25 | 15580305 | |
MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 27.25 | 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | Curcumin | 27.25 | 19196508 17440100 19401701 | |
MESH:D010190 | Pancreatic Neoplasms | decitabine | 27.25 | 19294695 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 27.25 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 27.25 | 15580305 | |
MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 27.25 | 16965848 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 27.25 | 15976015 | |
MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 27.25 | 19294695 | |
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 3.00 | 11578682 | |
MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 2.77 | 7296757 | |
MESH:D010235 | Paraganglioma | arsenic trioxide | 3.47 | 19927285 | |
MESH:D010300 | Parkinson Disease | Polychlorinated Biphenyls | 3.07 | 16702228 | |
MESH:D020734 | Parkinsonian Disorders | Melatonin | 4.39 | 15574749 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.49 | 12520081 | |
MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 3.61 | 15464296 | |
MESH:D010538 | Peritonitis | Melatonin | 4.60 | 15707874 | |
MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 3.72 | 6228378 | |
MESH:D010997 | Pleural Neoplasms | Cisplatin | 4.59 | 17638057 | |
MESH:D011014 | Pneumonia | Lipopolysaccharides | 3.82 | 11605937 12224865 | |
MESH:D017689 | Polydactyly | Phenytoin | 4.40 | 9212184 | |
MESH:D017499 | Porokeratosis | alitretinoin | 5.25 | 16144296 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 2.85 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 2.92 | 2563599 | |
MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 3.08 | 21297632 | |
MESH:D011225 | Pre-Eclampsia | Zinc | 3.58 | 17114810 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 12.14 | 10548101 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Isotretinoin | 12.14 | 18769834 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 12.14 | 11118676 11896295 11399792 11222880 | |
MESH:D055728 | Primary Myelofibrosis | decitabine | 10.02 | 17616702 | |
MESH:D055728 | Primary Myelofibrosis | trichostatin A | 10.02 | 17616702 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 14.18 | 20887781 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 14.18 | 20887781 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Testosterone | 14.18 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | Am 80 | 7.66 | 16289102 | |
MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 7.66 | 19131511 | |
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 7.66 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | bisphenol A | 7.66 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Cholecalciferol | 7.66 | 17024972 | |
MESH:D011471 | Prostatic Neoplasms | Curcumin | 7.66 | 18156803 11398177 12497104 18769126 15129424 10851300 18226269 | |
MESH:D011471 | Prostatic Neoplasms | Estradiol | 7.66 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Fenretinide | 7.66 | 17024972 | |
MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 7.66 | 15682402 12376480 | |
MESH:D011471 | Prostatic Neoplasms | Polychlorinated Biphenyls | 7.66 | 15721890 | |
MESH:D011471 | Prostatic Neoplasms | Raloxifene | 7.66 | 16220300 16536755 15731164 | |
MESH:D011471 | Prostatic Neoplasms | Retinoids | 7.66 | 16724957 16166285 | |
MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 7.66 | 15067354 | |
MESH:D011471 | Prostatic Neoplasms | trichostatin A | 7.66 | 18798265 19789329 | |
MESH:D011471 | Prostatic Neoplasms | vorinostat | 7.66 | 17218635 | |
MESH:D011471 | Prostatic Neoplasms | Zinc | 7.66 | 16700911 12429649 16606632 16517595 | |
MESH:D011507 | Proteinuria | Gentamicins | 7.27 | 15033597 | |
MESH:D011507 | Proteinuria | Tretinoin | 7.27 | 16636307 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 2.58 | 15861022 16919318 | |
MESH:D019310 | Pseudolymphoma | Phenytoin | 4.79 | 8603615 1419762 12752131 | |
MESH:D011565 | Psoriasis | Am 80 | 3.77 | 16819260 | |
MESH:D011596 | Psychomotor Disorders | Isotretinoin | 5.18 | 18769834 | |
MESH:D011625 | Pterygium | Tretinoin | 4.05 | 16723453 | |
MESH:D011629 | Puberty, Precocious | bisphenol A | 4.05 | 10548101 | |
MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.87 | 19168576 | |
MESH:D011693 | Purpura | Raloxifene | 4.80 | 15770314 | |
MESH:D051437 | Renal Insufficiency | Cisplatin | 8.27 | 15464296 | |
MESH:D051437 | Renal Insufficiency | Gentamicins | 8.27 | 15728788 17132701 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 7.04 | 10666014 18379247 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 7.04 | 18379247 11700416 | |
MESH:D012127 | Respiratory Distress Syndrome, Newborn | Vitamin A | 5.06 | 16877224 | |
MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 3.21 | 10835634 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.13 | 18990726 | |
MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 16.61 | 3692021 | |
MESH:D012162 | Retinal Degeneration | Fenretinide | 16.61 | 16303925 | |
MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 16.61 | 18155124 18172121 | |
MESH:D012162 | Retinal Degeneration | Zinc | 16.61 | 16584753 | |
MESH:D012173 | Retinitis | Gentamicins | 5.52 | 18644591 | |
MESH:D012175 | Retinoblastoma | Methylnitrosourea | 4.75 | 11555667 | |
MESH:D012208 | Rhabdomyosarcoma | decitabine | 8.66 | 19155313 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 8.66 | 16116481 16283617 | |
MESH:D012509 | Sarcoma | Curcumin | 3.47 | 18462866 | |
MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 8.01 | 16646077 | |
MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 8.01 | 14601052 | |
MESH:D020426 | Sciatic Neuropathy | marker/mechanism | 16782282 | ||
MESH:D012640 | Seizures | Dizocilpine Maleate | 5.28 | 17157343 12660363 11218047 | |
MESH:D012640 | Seizures | Phenytoin | 5.28 | 3691417 19919933 16876388 10029267 3137016 15946322 9844417 11044598 | |
MESH:D018805 | Sepsis | Curcumin | 3.46 | 18389075 | |
MESH:D012735 | Sexual Dysfunction, Physiological | Testosterone | 5.45 | 16631401 | |
MESH:D012871 | Skin Diseases | Vitamin A | 3.12 | 18709164 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 17.13 | 10029692 19755658 | |
MESH:D012878 | Skin Neoplasms | Fenretinide | 17.13 | 16467112 | |
MESH:D012878 | Skin Neoplasms | Okadaic Acid | 17.13 | 12628509 | |
MESH:D012878 | Skin Neoplasms | Retinoids | 17.13 | 17538947 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 17.13 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 17.13 | 16467112 | |
MESH:D012893 | Sleep Disorders | Melatonin | 4.73 | 16919138 16897403 18182647 | |
MESH:D020178 | Sleep Disorders, Circadian Rhythm | Melatonin | 5.88 | 18078449 19452292 | |
MESH:D007319 | Sleep Initiation and Maintenance Disorders | Melatonin | 4.51 | 18078449 | |
MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 4.59 | 15464296 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 9.06 | 16709447 | |
MESH:D013088 | Spermatocele | Tamoxifen | 9.06 | 16709447 | |
MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 3.30 | 19457130 | |
MESH:D013262 | Stevens-Johnson Syndrome | Phenytoin | 4.43 | 20235791 | |
MESH:D013272 | Stomach Diseases | beta Carotene | 8.17 | 17638125 | |
MESH:D013272 | Stomach Diseases | Dexamethasone | 8.17 | 15472012 | |
MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 8.50 | 17007042 | |
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 8.50 | 20155912 2093021 | |
MESH:D013274 | Stomach Neoplasms | Cisplatin | 8.50 | 15958060 18396642 17522103 | |
MESH:D013274 | Stomach Neoplasms | decitabine | 8.50 | 19037991 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 8.50 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 8.50 | 16257854 15930296 18593901 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 8.50 | 17261132 | |
MESH:D013276 | Stomach Ulcer | beta Carotene | 11.92 | 12500499 | |
MESH:D013276 | Stomach Ulcer | Curcumin | 11.92 | 16631530 19188055 | |
MESH:D013276 | Stomach Ulcer | Dexamethasone | 11.92 | 15138204 | |
MESH:D013276 | Stomach Ulcer | Melatonin | 11.92 | 11523592 16150113 12500499 | |
MESH:D020521 | Stroke | Raloxifene | 3.22 | 16837676 | |
MESH:D019966 | Substance-Related Disorders | bisphenol A | 3.25 | 16684133 16045194 | |
MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.94 | 17225452 15464296 | |
MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 7.96 | 15821434 | |
MESH:D013921 | Thrombocytopenia | vorinostat | 7.96 | 20479100 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.93 | 11994571 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.52 | 15669648 | |
MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 4.49 | 11418001 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.15 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 29.42 | 1399818 3712494 6587162 6582329 7505956 | |
MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 29.42 | 19014326 | |
MESH:D013964 | Thyroid Neoplasms | Butyrates | 29.42 | 17967635 | |
MESH:D013964 | Thyroid Neoplasms | decitabine | 29.42 | 17967635 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 29.42 | 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 29.42 | 3078959 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Retinoids | 29.42 | 16940797 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 29.42 | 16026305 17045167 | |
MESH:D013978 | Tibial Fractures | Estradiol | 11.21 | 19048282 | |
MESH:D013978 | Tibial Fractures | Raloxifene | 11.21 | 19048282 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 7.81 | 16051514 | |
MESH:D014062 | Tongue Neoplasms | Zinc | 7.81 | 16543248 | |
MESH:D016171 | Torsades de Pointes | arsenic trioxide | 3.23 | 15213294 | |
MESH:D014376 | Tuberculosis | Tretinoin | 2.72 | 16040207 | |
MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 25.84 | 8074119 | |
MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 25.84 | 12845720 20435036 12973940 11780464 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 25.84 | 17053015 | |
MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 25.84 | 15464296 12973940 17225452 | |
MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 25.84 | 18593936 | |
MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 25.84 | 19087683 17616700 | |
MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 25.84 | 16720286 | |
MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 25.84 | 17572228 | |
MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 25.84 | 17572228 16712894 8653321 | |
MESH:D014565 | Urogenital Neoplasms | Curcumin | 4.52 | 18462866 | |
MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 12.25 | 16803524 | |
MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 12.25 | 16154183 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 12.25 | 16129372 | |
MESH:D014591 | Uterine Diseases | bisphenol A | 4.25 | 14652134 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 2.60 | 14692618 | |
MESH:D014604 | Uveal Neoplasms | decitabine | 10.33 | 17785578 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 10.33 | 16752155 | |
MESH:D014605 | Uveitis | Dexamethasone | 4.06 | 1336536 | |
MESH:D014625 | Vaginal Neoplasms | Cisplatin | 3.89 | 15577323 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.84 | 12125929 | |
MESH:D054556 | Venous Thromboembolism | Raloxifene | 4.45 | 16837676 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.87 | 14671159 15869587 | |
MESH:D015837 | Vestibular Diseases | Gentamicins | 4.81 | 18776599 | |
MESH:D014802 | Vitamin A Deficiency | Vitamin A | 4.59 | 16146918 16175781 16960172 | |
MESH:D014820 | Vitiligo | Tretinoin | 3.35 | 16761959 | |
MESH:D014839 | Vomiting | Cisplatin | 3.97 | 11897121 | |
MESH:D014846 | Vulvar Neoplasms | Raloxifene | 4.80 | 16343187 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.49 | 15886252 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 3.33 | 16287080 |
Pathway ID | Pathway Name |
---|---|
KEGG:05221 | Acute myeloid leukemia |
KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
KEGG:04514 | Cell adhesion molecules (CAMs) |
KEGG:05414 | Dilated cardiomyopathy |
KEGG:04512 | ECM-receptor interaction |
KEGG:04510 | Focal adhesion |
REACT:71 | Gene Expression |
KEGG:05410 | Hypertrophic cardiomyopathy (HCM) |
KEGG:04672 | Intestinal immune network for IgA production |
KEGG:05200 | Pathways in cancer |
KEGG:04810 | Regulation of actin cytoskeleton |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB00210 | agonist | Adapalene | Dermatologic Agents |
DB00459 | agonist | Acitretin | Keratolytic Agents |
DB00523 | agonist | Alitretinoin | Antineoplastic Agents;Keratolytic Agents |
DB00799 | agonist | Tazarotene | Keratolytic Agents;Dermatologic Agents;Prodrugs;Teratogens |
DB00926 | agonist | Etretinate | Keratolytic Agents |
DB00982 | other/unknown | Isotretinoin | Antineoplastic Agents;Anti-acne Agents;Keratolytic Agents;Skin and Mucous Membrane Agents |
DB04942 | binder | Tamibarotene | Anticancer Agents |
No data |
No data |
No data |